DIAGNOSTICS DEFINING THERAPY

WIPO WIPO 2018

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark DIAGNOSTICS DEFINING THERAPY was filed as Word mark on 12/21/2018 at the World Intellectual Property Organization.

Trademark Details Last update: July 29, 2021

Trademark form Word mark
File reference 1467839
Countries China European Community Japan South Korea United States of America (USA)
Base trademark AU No. 1939288, July 6, 2018
Application date December 21, 2018
Expiration date December 21, 2028

Trademark owner

Suite G16,
National Innovation Centre,
AU

Trademark representatives

Level 14, 255 Elizabeth Street AU

goods and services

01 Chemicals used in industry, science, photography, agriculture, horticulture and forestry; reagents and reactants in this class; enzymes for industrial or scientific purposes; nucleic acid; nucleic recombinant acids; acids for industrial purposes; polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring
05 Pharmaceutical and veterinary preparations and substances; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes; enzymes for pharmaceutical, veterinary and medical purposes; medical kits containing medical and/or pharmaceutical preparations; clinical diagnostics for medical or veterinary use; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders
10 Surgical, medical and veterinary apparatus and instruments; diagnostic testing apparatus and instruments for medical purposes; diagnostic testing kits containing diagnostic testing apparatus; point of care medical devices; screening kits in this class for the diagnosis of disease, detection and/or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy
42 Scientific and technological services and research and design relating thereto; genetic research; genetic engineering services; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of diagnostic apparatus; design of diagnostic apparatus; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, dna, rna, protein, polynucleic acid and molecular analysis and evaluation services; dna and rna and polynucleic acid and protein sequencing, analysis and evaluation services; genome sequencing services and the analysis and evaluation of data resulting therefrom; provision of reports relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services; custom design and development of biochemical assays; molecular diagnostics testing
44 Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services relating to dna, genetics and genetic testing; medical diagnostic services (testing and analysis); providing collected and analysed medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; diagnostic imaging and molecular medicine

Trademark history

Date Document number Area Entry
February 18, 2021 2021/8 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
January 18, 2021 2021/3 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
November 23, 2020 2020/50 Gaz EM RAW: Rule 18ter(2)(ii) GP following a provisional refusal
September 6, 2020 2020/37 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
July 23, 2020 2020/30 Gaz JP Rejection
March 27, 2020 2020/14 Gaz KR Rejection
July 23, 2019 2019/31 Gaz CN Rejection
June 24, 2019 2019/26 Gaz US Rejection
June 13, 2019 2019/25 Gaz EM Rejection
December 21, 2018 2019/19 Gaz AU Registration

ID: 141467839